Join Growin Stock Community!

久裕4173.TW Overview

TW StockBiotech. & Medical
(No presentation for 4173)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

久裕(4173)Overall Performance

久裕(4173)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

久裕(4173) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

久裕(4173)Key Information

久裕(4173)Profile

Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It promotes prescription drugs and over the counter products. The company also provides logistics services consisting of pharmaceutical factory inventory management, logistics distribution, customer complaint handling management, and domestic transportation and distribution services, as well as warehousing and storage services. The company serves medical institutions, clinics, pharmacies, chain drugstores, and hypermarkets. Arich Enterprise Co., Ltd. was founded in 1969 and is headquartered in New Taipei City, Taiwan.

久裕(4173)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
20.10%
Net Margin
6.73%
Revenue Growth (YoY)
21.17%
Profit Growth (YoY)
19.66%
3-Year Revenue Growth
15.10%
3-Year Profit Growth
12.87%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
20.10%
Net Margin
6.73%
Revenue Growth (YoY)
21.17%
Profit Growth (YoY)
19.66%
3-Year Revenue Growth
15.10%
3-Year Profit Growth
12.87%
default symbol

4173

久裕

21.75D

-1.15%

(-0.01)

  • When is 4173's latest earnings report released?

    The most recent financial report for 久裕 (4173) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4173's short-term business performance and financial health. For the latest updates on 4173's earnings releases, visit this page regularly.

  • Where does 4173 fall in the P/E River chart?

    According to historical valuation range analysis, 久裕 (4173)'s current price-to-earnings (P/E) ratio is 15.06, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 4173?

    According to the latest financial report, 久裕 (4173) reported an Operating Profit of 15.5M with an Operating Margin of 4.21% this period, representing a decline of 23.98% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4173's revenue growth?

    In the latest financial report, 久裕 (4173) announced revenue of 367.74M, with a Year-Over-Year growth rate of 12.3%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4173 have?

    At the end of the period, 久裕 (4173) held Total Cash and Cash Equivalents of 739.93M, accounting for 0.13 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4173 go with three margins increasing?

    In the latest report, 久裕 (4173) achieved the “three margins increasing” benchmark, with a gross margin of 18.26%%, operating margin of 4.21%%, and net margin of 4.57%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4173's profit trajectory and future growth potential.

  • Is 4173's EPS continuing to grow?

    According to the past four quarterly reports, 久裕 (4173)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.23. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4173?

    久裕 (4173)'s Free Cash Flow (FCF) for the period is 25.27M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 60.19% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.